Atralin Articles
Dr Reddy's launches Nexret in India
29 April 2009
Valeant in deal to buy Coria Labs
29 September 2008
Steifel acquires Barrier in $145M deal
30 June 2008
Barrier's Solage performs well in dark skin types
22 January 2007
Barrier gains US/Canadian rights to Solage topical solution
14 February 2005
AP Pharma's 1st-qtr net loss jumps 42%
3 May 2004
Preliminary results for Helix' anti-wrinkle peptide
29 March 2004
AP Pharma's 4th-qtr and 2003 net losses climb
22 March 2004
Connetics sees 4th-qtr product revenues rise 50%
3 February 2003
AP Pharma revenues double
11 March 2002
Antigenics looking to raise $60 million.
21 January 2002
Retin-A Micro cleared in Canada
26 July 2001
Antigenics to acquire Aronex Pharmaceuticals
27 April 2001
Aronex looking at strategic options
7 February 2001
Aronex' Atragen denied by FDA again
10 January 2001
FDA accepts Aronex' Atragen NDA amendment
23 August 2000
Aronex re-seeks approval for Atragen
25 May 2000
Aronex to file NDA amendment
23 December 1999
Aronex' Atragen not approvable, says FDA
27 September 1999
Aronex's Atragen NDA is "insufficient"
6 August 1999
Senetek & ICN Agreement For AdrenaJect (ReliaJect)
29 October 1998
Alpharma To Market First Generic Retin-A
21 May 1998
Tazarotene - 1st Effective Topical Retinoid For Psoriasis?
18 September 1997
Aronex' Atragen Set For Filing End-97
7 April 1997
Advanced Polymer's First Rx Product Cleared In USA
17 February 1997
APS' Ethical Drug Delivery Business Nears Fruition
11 November 1996
Biopharmaceutical Firms Report On 2nd Qtr
12 August 1996
Results Of Geneda Corp's B-2 Actigen Pilot Study
17 June 1996
Renova Launched In USA
19 February 1996
Ortho Pharmaceutical's Renova: FDA news
8 January 1996
Progress Towards Goals By US BioPharma Firms
4 December 1995
Roche's Vesanoid Approved In USA
4 December 1995
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Ligand/Allergan Start ALRT1057 Trials
12 June 1995
Ortho Launch
24 April 1995
Launch of Vesanoid In Japan
17 April 1995
Ortho Fined For Shredding Documents Regarding Retin-A
17 April 1995
Advanced Polymer Submission
13 February 1995
Ortho To Plead Guilty Over Retin-A
16 January 1995
Japanese Year End Approvals
9 January 1995
Review For Vesanoid
2 January 1995
Vesanoid Reviewed By FDA Committee
19 December 1994
KIDDER, PEABODY ON BIOTECHNOLOGY
2 May 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
GENZYME TO MARKET ARGUS' TRETINOIN LF
20 September 1993
ORTHO'S RETIN-A TESTED FOR SUNBURNT SKIN
6 September 1993
RETIN-A IN CERVICAL DYSPLASIA
24 May 1993
ARGUS CLINICAL TRIALS
3 May 1993
US CONGRESS REPORT ON OFF-LABEL PROMOTION
7 December 1992
RENOVA THE FIRST COSMECEUTICAL
7 September 1992
Showing 1-58 of 58 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
